20 Jul Orca Bio
Posted at 21:00h
in
Mike Hirschmann, Chief Commercial Officer
Oct. 6 | 11:30am | FLW Ballroom F
Menlo Park, CA
(Private)
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. The company’s manufacturing platform uses single-cell precision to create proprietary, uniquely defined products designed to replace a patient’s diseased blood and immune system with a healthy one. At Orca Bio, we are on a mission to redefine what’s possible for patients by transforming the field of curative allogeneic cell therapy.